Steve Pearson stepping down as ICER president: an exit interview

Steve Pearson, one of the most controversial voices in the biopharma ecosystem, announced Wednesday that he’s stepping down at the end of the year as president of ICER. Sarah K. Emond, ICER’s EVP and COO, will replace Pearson. He will continue to serve as an adviser to the organization through the end of 2024.

Pearson founded Institute for Clinical and Economic Review (ICER) in 2006 and has led the non-profit as it has become the most prominent source in the U.S. of evidence and analyses on the effectiveness and value of medicines. ...